Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anand Vaishnav, M.D.
University of Louisville
Principal Investigator - Arbi G Ohanian, MD
Huntington Memorial Hospital
Principal Investigator - David Brown, MD
Hoag Memorial Hospital Presbyterian
Principal Investigator - Jeff Saver, MD
UCLA Stroke Center
Principal Investigator - Mauricio Concha, M.D.
Sarasota Memorial Hospital
Principal Investigator - Nobl Barazangi, M.D.
California Pacific Medical Center Research Institute
Principal Investigator - Sidney Starkman, MD
UCLA Stroke Center
Principal Investigator - Stephan A Mayer, M.D.
Columbia University
Principal Investigator - Thomas G Devlin, M.D.
University Erlanger Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucla Stroke Center (departments of Emergency Medicine and Neurology at the University of California, Los Angeles Medical Center)
Los Angeles, California, United States
- Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
- Huntington Memorial Hospital Stroke Center
Pasadena, California, United States
- California Pacific Medical Center Research Institute
San Francisco, California, United States
- Sarasota Memorial Hospital
Sarasota, Florida, United States
- University of Louisville
Louisville, Kentucky, United States
- Columbia University Medical Center
New York, New York, United States
- University Erlanger Hospital
Chattanooga, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Mar 2011
- Primary completion
- 7 Jul 2016
- Completion
- 7 Jul 2016
- Last update posted
- 12 Aug 2019
- Registered enrollment
- 34
- Registry id
- NCT01221246
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.